AURORA CANNABIS INC Logo

AURORA CANNABIS INC

A global producer and seller of medical and recreational cannabis and derivative products.

ACB | US

Overview

Corporate Details

ISIN(s):
CA05156X8843
LEI:
Country:
United States of America
Address:
2207 90B STREET SW, EDMONTON
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Aurora Cannabis Inc. is a Canadian-licensed company engaged in the production, distribution, and sale of medical and recreational cannabis and cannabis-derivative products. The company's operations span multiple continents, offering a diverse portfolio that includes dried cannabis, cannabis oils, and various consumer products under brands such as Aurora, Aurora Drift, San Rafael '71, and Daily Special. Aurora focuses on the entire value chain, from cultivation and production to patient education and sales, with a particular emphasis on science-based medical cannabis solutions for the Canadian and international markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all AURORA CANNABIS INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AURORA CANNABIS INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for AURORA CANNABIS INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Mereo BioPharma Group plc Logo
A clinical-stage biopharma developing and commercializing novel therapies for rare diseases.
United States of America MREO
Mersana Therapeutics, Inc. Logo
Developing innovative antibody-drug conjugates using proprietary platforms to treat cancer.
United States of America MRSN
Merus N.V. Logo
Develops multispecific antibody therapies that harness the immune system to fight cancer.
United States of America MRUS
MESOBLAST LTD Logo
Develops off-the-shelf cellular medicines for complex inflammatory and chronic diseases.
United States of America MESO
Metagenomi, Inc. Logo
Discovering novel gene editing tools from nature for curative genetic medicines.
United States of America MGX
MetaVia Inc. Logo
A clinical-stage biotech developing novel drugs for cardiometabolic diseases like obesity and MASH.
United States of America MTVA
Metsera, Inc. Logo
Develops potent, long-acting oral & injectable therapies for obesity & metabolic diseases.
United States of America MTSR
Mezzion Pharma Co., Ltd. Logo
Develops and out-licenses novel therapeutics like udenafil, with a focus on rare diseases.
South Korea 140410
MFC Co., Ltd. Logo
A GMP-certified CDMO/CMO developing and manufacturing APIs for the global pharma sector.
South Korea 432980
Milestone Pharmaceuticals Inc. Logo
Developing a self-administered nasal spray for at-home treatment of acute cardiac events.
United States of America MIST

Talk to a Data Expert

Have a question? We'll get back to you promptly.